Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 USD | +15.79% | +45.28% | +15.79% |
May. 13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
May. 09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.79% | 48.17M | |
-25.12% | 16.69B | |
-45.71% | 2.68B | |
+24.57% | 1.97B | |
-10.64% | 1.49B | |
+27.97% | 1.3B | |
-14.14% | 989M | |
+4.20% | 807M | |
-29.96% | 801M | |
-24.44% | 633M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating